Nishimura Wester Eidi, Costallat Lilian Tereza Lavras, Fernandes Sandra Regina Muchinechi, Conde Roseneide Aparecida, Bertolo Manoel Barros
Universidade Estadual de Campinas- FCM, Unicamp.
Rev Bras Reumatol. 2012 May-Jun;52(3):366-74.
To evaluate the frequency of HLA classes I and II and their association with the cutaneous manifestation of rheumatoid vasculitis (RV) in Brazilian patients.
During one year we selected 130 patients with rheumatoid arthritis (RA) classified according to the American College of Rheumatology, 1987. All patients underwent a clinical and laboratory questionnaire to exclude other causes of cutaneous vasculopathy (neoplasia, infections, illicit drug use, diabetes mellitus, and tobaccoism). Seventy-three patients with any risk factor for other causes of vasculopathy were excluded. Fifty-seven without risk factors for other causes of vasculopathy were included in the study, 17 with RV according to Scott and Bacon's criteria, 1984. Demographic data, time of RA diagnosis, disease activity (DAS28), presence of rheumatoid factor, and anti-cyclic citrullinated peptide antibodies were analyzed. The HLA alleles were typed using the DNA-amplified polymerase chain reaction with low-resolution hybridization and sequence-specific primers.
The comparison between the 40 patients without RV and the 17 patients with RV showed an increased frequency of HLA-B14 (Pc = 0.168) and HLA-Cw08 (Pc = 0.084) in patients with RV and an increased frequency of HLA-DRB5*01 (Pc = 0.048) in patients without RV.
The HLA-DRB5*01 may confer protection against that extra-articular manifestation of RA.
